Results 181 to 190 of about 14,443 (215)

Antithrombin III concentrate: its catabolism in health and in antithrombin III deficiency

Scandinavian Journal of Clinical and Laboratory Investigation, 1981
The catabolism of purified radiolabelled antithrombin III (AT III) concentrate was studied in two normals and two patients with congenital AT III deficiency both alone and combined with warfarin. The radiolabelling with iodine monochloride did not change the quality of the concentrate. The half-life varied between 3.4 and 4.8 days.
L, Tengborn, B, Frohm, L E, Nilsson, I M, Nilsson   +3 more
openaire   +2 more sources

Thrombosis in Antithrombin-III Deficiency

Annals of Internal Medicine, 1992
Excerpt To the Editors:Demers and colleagues (1) reported on the prevalence of thrombosis in antithrombin-III-deficient patients.
Valerio De Stefano, Giuseppe Leone
openaire   +1 more source

Antithrombin III deficiency in pregnancy

Primary Care Update for OB/GYNS, 1999
Abstract Thromboembolism is one of the most significant and common medical problems occurring during pregnancy. Some pregnant women are at a higher risk of thromboembolism because of inheritable hypercoagulable states. Antithrombin III deficiency is one of the inheritable coagulable states that may lead to an increase in thromboembolism during ...
Laurie S Swaim, Larry C Gilstrap
openaire   +1 more source

Replacement Therapy in Antithrombin III Deficiency

Transfusion Medicine Reviews, 1989
NTITHROMBIN III (ATIll) has two impor­ tant roles in hemostasis; it is the predomi­ nant circulating inhibitor of clotting factors acti­ vated during blood coagulation, and the major heparin cofactor in plasma. 1 Its key modulatory function is clearly illustrated by the long-recog­ nized causal relationship between inherited an­ tithrombin deficiency ...
openaire   +2 more sources

Antithrombin III replacement in animal models of acquired antithrombin III deficiency

Blood Coagulation & Fibrinolysis, 1994
Plasma antithrombin III (AT III) levels decrease early during Gram-negative septicaemia, and even a moderate decrease in this major inhibitor of the coagulation system is associated with serious disseminated intravascular coagulation (DIC). This study reports the efficacy of high dose (at least 250 units/kg) AT III replacement in three animal models of
openaire   +2 more sources

Familial antithrombin III deficiency.

British medical journal, 1978
H A de Haas, M F Scully, S E Clark, V V Kakkar   +3 more
  +5 more sources

Antithrombin III Deficiency and Thromboembolism

Clinics in Haematology, 1981
E, Thaler, K, Lechner
openaire   +2 more sources

[Acquired antithrombin III deficiency].

Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1992
Acquired antithrombin III (AT III) deficiency is based on either decreased activity or synthesis, increased loss or increased consumption. The activity of AT III is decreased in metabolic acidosis, hyperlipoproteinemias and by lipid peroxides. Chronic liver diseases especially liver cirrhosis are associated with very low levels of AT III due to ...
openaire   +1 more source

[Danazol and antithrombin III deficiency].

Journal des maladies vasculaires, 1990
The study concerned 7 subjects (3 men, 4 women) with nonfamilial antithrombin III deficit which, in the absence of known causes of acquired deficiency, was defined as "sporadic". Danazol (an attenuated synthetic androgen) already shown to be capable of compensating for a lack of certain antiproteases, was given in doses of 200 mg 3 times per day for 10
M, Lucchi, S, Bilancini
openaire   +1 more source

Congenital antithrombin III deficiency

The American Journal of Medicine, 1989
Jack Hirsh, Franco Piovella, Mario Pini
openaire   +1 more source